131 related articles for article (PubMed ID: 9781025)
1. Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2).
Schuffenhauer S; Lichtner P; Peykar-Derakhshandeh P; Murken J; Haas OA; Back E; Wolff G; Zabel B; Barisic I; Rauch A; Borochowitz Z; Dallapiccola B; Ross M; Meitinger T
Eur J Hum Genet; 1998; 6(3):213-25. PubMed ID: 9781025
[TBL] [Abstract][Full Text] [Related]
2. DiGeorge anomaly and chromosome 10p deletions: one or two loci?
Dasouki M; Jurecic V; Phillips JA; Whitlock JA; Baldini A
Am J Med Genet; 1997 Nov; 73(1):72-5. PubMed ID: 9375926
[TBL] [Abstract][Full Text] [Related]
3. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
[TBL] [Abstract][Full Text] [Related]
4. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.
Lindsay EA; Halford S; Wadey R; Scambler PJ; Baldini A
Genomics; 1993 Aug; 17(2):403-7. PubMed ID: 8406492
[TBL] [Abstract][Full Text] [Related]
6. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. A review.
Demczuk S; Aurias A
Ann Genet; 1995; 38(2):59-76. PubMed ID: 7486827
[TBL] [Abstract][Full Text] [Related]
7. Interstitial deletion of 10p and atrial septal defect in DiGeorge 2 syndrome.
Yatsenko SA; Yatsenko AN; Szigeti K; Craigen WJ; Stankiewicz P; Cheung SW; Lupski JR
Clin Genet; 2004 Aug; 66(2):128-36. PubMed ID: 15253763
[TBL] [Abstract][Full Text] [Related]
8. DiGeorge syndrome and partial monosomy 10p: case report and review.
Schuffenhauer S; Seidel H; Oechsler H; Belohradsky B; Bernsau U; Murken J; Meitinger T
Ann Genet; 1995; 38(3):162-7. PubMed ID: 8540688
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic characterization of a 10p14 deletion that includes the DGS2 region in a patient with multiple anomalies.
Skrypnyk C; Goecke TO; Majewski F; Bartsch O
Am J Med Genet; 2002 Nov; 113(2):207-12. PubMed ID: 12407714
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
[TBL] [Abstract][Full Text] [Related]
11. Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene.
Budarf ML; Collins J; Gong W; Roe B; Wang Z; Bailey LC; Sellinger B; Michaud D; Driscoll DA; Emanuel BS
Nat Genet; 1995 Jul; 10(3):269-78. PubMed ID: 7670464
[TBL] [Abstract][Full Text] [Related]
12. Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p.
Lichtner P; Attié-Bitach T; Schuffenhauer S; Henwood J; Bouvagnet P; Scambler PJ; Meitinger T; Vekemans M
J Mol Med (Berl); 2002 Jul; 80(7):431-42. PubMed ID: 12110949
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit.
Berti L; Mittler G; Przemeck GK; Stelzer G; Günzler B; Amati F; Conti E; Dallapiccola B; Hrabé de Angelis M; Novelli G; Meisterernst M
Genomics; 2001 Jun; 74(3):320-32. PubMed ID: 11414760
[TBL] [Abstract][Full Text] [Related]
14. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
15. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
Driscoll DA
Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Registry screening for DiGeorge Critical Region deletion using loss of heterozygosity analysis.
Katzman PJ; Smoot LB; Cox GF
Pediatr Dev Pathol; 2006; 9(4):266-79. PubMed ID: 16944986
[TBL] [Abstract][Full Text] [Related]
17. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
[TBL] [Abstract][Full Text] [Related]
18. An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14.
Lichtner P; König R; Hasegawa T; Van Esch H; Meitinger T; Schuffenhauer S
J Med Genet; 2000 Jan; 37(1):33-7. PubMed ID: 10633131
[TBL] [Abstract][Full Text] [Related]
19. Hypocalcemia impacts heart failure control in DiGeorge 2 syndrome.
Chao PH; Chao MC; Hwang KP; Chung MY
Acta Paediatr; 2009 Jan; 98(1):195-8. PubMed ID: 18795911
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization.
Demczuk S; Desmaze C; Aikem M; Prieur M; Ledeist F; Sanson M; Rouleau G; Thomas G; Aurias A
Ann Genet; 1994; 37(2):60-5. PubMed ID: 7985979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
